
|Articles|May 1, 2004
Urea vehicle promotes tolerability of topical acne medication
Washington, D.C. - A unique urea-containing vehicle appears to improve the tolerability of topical treatment with sodium sulfacetamide/sulfur in acne and rosacea patients with sensitive skin, according to the results of a randomized, double-blind, active comparator-controlled study presented by James J. Leyden, M.D., at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5

















